GLOB.HEALTH CLINICS O.N. (L00) - Cash Flow Conversion Efficiency

Latest as of January 2026: 0.032x

Based on the latest financial reports, GLOB.HEALTH CLINICS O.N. (L00) has a cash flow conversion efficiency ratio of 0.032x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-163.83K ≈ $-191.53K USD) by net assets (€-5.20 Million ≈ $-6.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GLOB.HEALTH CLINICS O.N. balance sheet quality to measure how much of total assets are equity-financed.

GLOB.HEALTH CLINICS O.N. - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how GLOB.HEALTH CLINICS O.N.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how well can GLOB.HEALTH CLINICS O.N. service its debt to assess how comfortably operating cash covers total debt obligations.

GLOB.HEALTH CLINICS O.N. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GLOB.HEALTH CLINICS O.N. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CuChi Commercial and Industrial Developing Investment JSC VN:CCI	N/A
Sunworks Inc NASDAQ:SUNWQ	-0.407x
Totally PLC LSE:TLY	0.004x
Renova Energia S.A SA:RNEW11	0.000x
Orient Telecoms LSE:ORNT	-2.282x
Jade Road Investments Ltd LSE:JADE	0.001x
CIC39 Corp VN:C32	N/A
Society Pass Inc NASDAQ:SOPA	-1.219x

Annual Cash Flow Conversion Efficiency for GLOB.HEALTH CLINICS O.N. (2022–2025)

The table below shows the annual cash flow conversion efficiency of GLOB.HEALTH CLINICS O.N. from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of GLOB.HEALTH CLINICS O.N..

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	€-4.53 Million ≈ $-5.29 Million	€-572.21K ≈ $-668.97K	0.126x	-16.96%
2024-07-31	€-3.26 Million ≈ $-3.81 Million	€-496.55K ≈ $-580.52K	0.152x	-67.08%
2023-07-31	€-2.18 Million ≈ $-2.55 Million	€-1.01 Million ≈ $-1.18 Million	0.462x	-82.63%
2022-07-31	€-559.58K ≈ $-654.21K	€-1.49 Million ≈ $-1.74 Million	2.661x	--

About GLOB.HEALTH CLINICS O.N.

F:L00 Germany Drug Manufacturers - Specialty & Generic

Market Cap

$5.49K

€4.70K EUR

Market Cap Rank

#31720 Global

#2876 in Germany

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.06

All Time High

€182.00